These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 26984316)

  • 21. A Fluorescent Teixobactin Analogue.
    Morris MA; Malek M; Hashemian MH; Nguyen BT; Manuse S; Lewis K; Nowick JS
    ACS Chem Biol; 2020 May; 15(5):1222-1231. PubMed ID: 32045203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple attack on bacteria by the new antibiotic teixobactin.
    von Nussbaum F; Süssmuth RD
    Angew Chem Int Ed Engl; 2015 Jun; 54(23):6684-6. PubMed ID: 25968231
    [No Abstract]   [Full Text] [Related]  

  • 23. Teixobactin as a scaffold for unlimited new antimicrobial peptides: SAR study.
    Abdel Monaim SAH; Jad YE; El-Faham A; de la Torre BG; Albericio F
    Bioorg Med Chem; 2018 Jun; 26(10):2788-2796. PubMed ID: 29029900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery, synthesis, and optimization of teixobactin, a novel antibiotic without detectable bacterial resistance.
    Qi YK; Tang X; Wei NN; Pang CJ; Du SS; Wang K
    J Pept Sci; 2022 Nov; 28(11):e3428. PubMed ID: 35610021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, Synthesis, and Study of Lactam and Ring-Expanded Analogues of Teixobactin.
    Yang H; Pishenko AV; Li X; Nowick JS
    J Org Chem; 2020 Feb; 85(3):1331-1339. PubMed ID: 31746604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomewide Profiling of the Enterococcus faecalis Transcriptional Response to Teixobactin Reveals CroRS as an Essential Regulator of Antimicrobial Tolerance.
    Darnell RL; Knottenbelt MK; Todd Rose FO; Monk IR; Stinear TP; Cook GM
    mSphere; 2019 May; 4(3):. PubMed ID: 31068434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of iChip to Grow "Uncultivable" Microorganisms and its Impact on Antibiotic Discovery.
    Sherpa RT; Reese CJ; Montazeri Aliabadi H
    J Pharm Pharm Sci; 2015; 18(3):303-15. PubMed ID: 26517134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of teixobactin analogues containing hydrophobic, non-proteogenic amino acids that are highly potent against multidrug-resistant bacteria and biofilms.
    Parmar A; Lakshminarayanan R; Iyer A; Goh ETL; To TY; Yam JKH; Yang L; Newire E; Robertson MC; Prior SH; Breukink E; Madder A; Singh I
    Eur J Med Chem; 2023 Dec; 261():115853. PubMed ID: 37857144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and antibacterial activity of tripropeptin C derivatives modified at the carboxyl groups.
    Hirosawa S; Takahashi Y; Hashizume H; Miyake T; Akamatsu Y
    J Antibiot (Tokyo); 2014 Mar; 67(3):265-8. PubMed ID: 24301184
    [No Abstract]   [Full Text] [Related]  

  • 30. Antimicrobial activities and action mechanism studies of transportan 10 and its analogues against multidrug-resistant bacteria.
    Xie J; Gou Y; Zhao Q; Li S; Zhang W; Song J; Mou L; Li J; Wang K; Zhang B; Yang W; Wang R
    J Pept Sci; 2015 Jul; 21(7):599-607. PubMed ID: 25891396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dissecting the Binding Interactions of Teixobactin with the Bacterial Cell-Wall Precursor Lipid II.
    Chiorean S; Antwi I; Carney DW; Kotsogianni I; Giltrap AM; Alexander FM; Cochrane SA; Payne RJ; Martin NI; Henninot A; Vederas JC
    Chembiochem; 2020 Mar; 21(6):789-792. PubMed ID: 31552694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Quality control of antimicrobial susceptibility testing by disk diffusion test].
    Ma Y; Li JY; Jin SH
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):355-6. PubMed ID: 15558846
    [No Abstract]   [Full Text] [Related]  

  • 33. A new antibiotic kills pathogens without detectable resistance.
    Ling LL; Schneider T; Peoples AJ; Spoering AL; Engels I; Conlon BP; Mueller A; Schäberle TF; Hughes DE; Epstein S; Jones M; Lazarides L; Steadman VA; Cohen DR; Felix CR; Fetterman KA; Millett WP; Nitti AG; Zullo AM; Chen C; Lewis K
    Nature; 2015 Jan; 517(7535):455-9. PubMed ID: 25561178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxazoline-based antimicrobial oligomers: synthesis by CROP using supercritical CO2.
    Correia VG; Bonifácio VD; Raje VP; Casimiro T; Moutinho G; da Silva CL; Pinho MG; Aguiar-Ricardo A
    Macromol Biosci; 2011 Aug; 11(8):1128-37. PubMed ID: 21674806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel and efficient one step synthesis of 2-amino-5-cyano-6-hydroxy-4-aryl pyrimidines and their anti-bacterial activity.
    Deshmukh MB; Salunkhe SM; Patil DR; Anbhule PV
    Eur J Med Chem; 2009 Jun; 44(6):2651-4. PubMed ID: 19036478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Teixobactin: a novel anti-infective agent.
    McCarthy MW
    Expert Rev Anti Infect Ther; 2019 Jan; 17(1):1-3. PubMed ID: 30449226
    [No Abstract]   [Full Text] [Related]  

  • 37. Investigation of the N-Terminus Amino Function of Arg
    Monaim SAHA; Noki S; Ramchuran EJ; El-Faham A; Albericio F; Torre BG
    Molecules; 2017 Sep; 22(10):. PubMed ID: 28956840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Total synthesis of lysobactin.
    Guzman-Martinez A; Lamer R; VanNieuwenhze MS
    J Am Chem Soc; 2007 May; 129(18):6017-21. PubMed ID: 17432854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Total Synthesis of Teixobactin.
    Giltrap AM; Dowman LJ; Nagalingam G; Ochoa JL; Linington RG; Britton WJ; Payne RJ
    Org Lett; 2016 Jun; 18(11):2788-91. PubMed ID: 27191730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and preliminary biological characterization of new semisynthetic derivatives of ramoplanin.
    Ciabatti R; Maffioli SI; Panzone G; Canavesi A; Michelucci E; Tiseni PS; Marzorati E; Checchia A; Giannone M; Jabes D; Romano G; Brunati C; Candiani G; Castiglione F
    J Med Chem; 2007 Jun; 50(13):3077-85. PubMed ID: 17542573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.